Related Experiment Video
Updated: Jul 14, 2026
04:30
Stimulated Single Fiber Electromyography (SFEMG) for Assessing Neuromuscular Junction Transmission in Rodent Models
Published on: March 8, 2024
Priming with rocuronium accelerates neuromuscular block in children: a prospective randomized study
Matthias Bock1, Lars Haselmann, Bernd W Böttiger
1Department 1 of Anesthesiology, Bozen Central Hospital, Bozen, Italy. matthias.bock@asbz.it
Summary
Priming with rocuronium significantly speeds up neuromuscular blockade onset in pediatric patients. A one-minute priming interval with 1.5 times the effective dose (ED95) achieved a block onset similar to a single 2.0 ED95 dose.
Area of Science:
- Anesthesiology and Pharmacology
- Pediatric Critical Care
Background:
- Rocuronium is a neuromuscular blocking agent used in pediatric anesthesia.
- Optimizing the onset of neuromuscular blockade is crucial for efficient surgical procedures.
Purpose of the Study:
- To evaluate the impact of a priming technique on the onset time and duration of action of rocuronium in children.
- To compare different priming doses (1.5 x ED(95) and 2.0 x ED(95)) of rocuronium.
Main Methods:
- A randomized controlled trial involving 84 pediatric patients (age 1-7 years) undergoing elective surgery.
- Neuromuscular function assessed via accelerometry and train-of-four (TOF) stimulation.
- Four groups: placebo followed by rocuronium (1.5x or 2.0x ED(95)) or priming dose followed by a larger bolus dose.
Main Results:
- Priming with rocuronium significantly reduced the onset time to maximum neuromuscular block compared to placebo.
- The 1.5x ED(95) priming group showed an onset comparable to the 2.0x ED(95) single-dose group.
- Spontaneous recovery was dose-dependent and unaffected by the priming strategy.
Conclusions:
- Priming with rocuronium effectively accelerates neuromuscular blockade onset in pediatric patients.
- A one-minute priming interval with 1.5x ED(95) rocuronium provides an onset similar to a 2.0x ED(95) single dose.
- This priming technique can optimize rocuronium's clinical application in pediatric surgery.
Related Concept Videos
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
01:19Depolarizing Blockers: Pharmocokinetics
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
01:11Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
01:28Depolarizing Blockers: Mechanism of Action
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...